Name: Latest research reports of Concord Biotech Ltd. authored by SBI Securities and published by - Trendlyne research reports.
Item: Concord Biotech Ltd.
Rating: 3
Author: SBI Securities

Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960 | ISIN: INE338H01029 | Industry: Biotechnology
| Expensive Performer

1678.7000 -33.60 (-1.96%)

NSE Apr 22, 2025 15:31 PM

36.99% Fall from 52W High

Volume: 53,564

Concord Biotech Ltd.

04 Aug 2023

1678.70

-1.96%

Concord Biotech limited IPO Note

IPO Note: Concord Biotech Ltd.

SBI Securities

Concord Biotech Ltd. is trading above its 30 day SMA of 1673.4